Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Marisa Dolled"'
Autor:
Steffen Filskov Sorensen, Wei Zhou, Marisa Dolled-Filhart, Jeanette Baehr Georgsen, Zhen Wang, Kenneth Emancipator, Dianna Wu, Michael Busch-Sørensen, Peter Meldgaard, Henrik Hager
Publikováno v:
Translational Oncology, Vol 9, Iss 1, Pp 64-69 (2016)
BACKGROUND: Recent clinical trial results have suggested that programmed cell death ligand 1 (PD-L1) expression measured by immunohistochemistry may predict response to anti–programmed cell death 1 (PD-1) therapy. Results on the association between
Externí odkaz:
https://doaj.org/article/74707ba9a0df40f4a1f4ff206a46e042
Publikováno v:
Cancer Informatics, Vol 7, Pp 29-40 (2009)
Missing data pose one of the greatest challenges in the rigorous evaluation of biomarkers. The limited availability of specimens with complete clinical annotation and quality biomaterial often leads to underpowered studies. Tissue microarray studies,
Externí odkaz:
https://doaj.org/article/984e8c44155144058dd3955d8f7ec676
Autor:
David L. Rimm, Robert L. Camp, Malini Harigopal, Karin Jirström, Melissa Cregger, Lisa Rydén, Marisa Dolled-Filhart
Purpose: A multitude of breast cancer mRNA profiling studies has stratified breast cancer and defined gene sets that correlate with outcome. However, the number of genes used to predict patient outcome or define tumor subtypes by RNA expression studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb5895e444c83ec6647f36d77f089b5
https://doi.org/10.1158/1078-0432.c.6518493
https://doi.org/10.1158/1078-0432.c.6518493
Autor:
David L. Rimm, Robert L. Camp, Malini Harigopal, Karin Jirström, Melissa Cregger, Lisa Rydén, Marisa Dolled-Filhart
Supplementary Information and Table 1 from Classification of Breast Cancer Using Genetic Algorithms and Tissue Microarrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b143948a58f5456a152b4ccd3805d9c3
https://doi.org/10.1158/1078-0432.22441416.v1
https://doi.org/10.1158/1078-0432.22441416.v1
Autor:
Yoon-La Choi, Kenneth Emancipator, Jong-Mu Sun, Mary Anne Rutkowski, Jong Ho Cho, Jhingook Kim, Hyejoo Choi, Tae-Eun Kim, Wei Zhou, Marisa Dolled-Filhart
Publikováno v:
Cancer Research and Treatment. 50:95-102
Purpose Data are limited on programmed death ligand 1 (PD-L1) expression in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Materials and methods We retrospectively evaluated the relationship between PD-L1 expressio
Autor:
Abrar Alturkistani, Juanjuan An, Norbert Benda, Karina Bienfait, Adele R. Blackler, Martin Bøgsted, David Brindley, Karl Broich, Rasmus F. Brøndum, Patrick Brunhoeber, Matthew Bureau, Josip Car, Alison Carter, Tara Clarke, June Clements, Darren Cross, Brett Doble, Marisa Dolled-Filhart, Elena Domazetoski, Mark W. Duncan, Ehab A. ElGabry, Aaron R. Ellison, Kenneth Emancipator, Harald Enzmann, Maria Farooq, Janine Feng, Kimberley Foley, Evgenii Generalov, Ning Fei Go, Alexey Goltsov, George A. Green, Maria Hersom, Narimon Honarpour, Lahiru Iddamalgoda, Masayuki Ikeda, Suzanne Jenkins, Jan Trøst Jørgensen, Monesh Kapadia, Sylwia Karwowska, Sebnem S. Kuzulugil, Ching Lam, Jason S. Lewis, Jinbo Li, Oliver Liesenfeld, Gilberto Lopes, Dee Luo, Edward Meinert, Ralf Meyer, Amita Mistry, Nicholas Mitsakakis, Jens Mollerup, Michael C. Montalto, Lauren B. Murata, Muhammed Murtaza, Karsten Bork Nielsen, Saumya Pant, Jayson L. Parker, Patrícia M.R. Pereira, Manjunath Ramarao, Ted Rigl, Oliver Schildgen, Verena Schildgen, Catharina Scholl, Sidney A. Scudder, Donna Seyfried, Abha Sharma, Rumiko Shimazawa, Richard Simon, Shalini Singh, Nicholas B. Sobol, David A. Stanforth, Julia Stingl, Vijayaraghava Seshadri Sundararajan, Prashanth Suravajhala, Alessandra Tosolini, Jeff Tsou, Kathryn M. Tully, Eric E. Walk, Dianna Wu, Xiaolei Xu, Karen Yu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6486bed3732fa46213d3cbf9f5daccdf
https://doi.org/10.1016/b978-0-12-813539-6.00033-x
https://doi.org/10.1016/b978-0-12-813539-6.00033-x
Autor:
Kenneth Emancipator, Dianna Wu, Alessandra Tosolini, Jeff Tsou, Marisa Dolled-Filhart, Karina L. Bienfait
There is a broad appreciation for the lack of standard operating procedures in the collection, processing, shipping, and storage of tissue samples obtained during clinical trials. This is intensified in the context of clinical sample collection that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c45954746b0e3c3922775789e40ad65f
https://doi.org/10.1016/b978-0-12-813539-6.00013-4
https://doi.org/10.1016/b978-0-12-813539-6.00013-4
Autor:
Catherine Dubos Arvis, Joo Hang Kim, Marcelo Garrido, Paul Baas, Margarita Majem, Gregory M. Lubiniecki, Mary J. Fidler, Marisa Dolled-Filhart, Gilberto de Castro, Enriqueta Felip, Yue Shentu, Julian R. Molina, Roy S. Herbst, Myung-Ju Ahn, Jose Luis Perez-Gracia, Dong Wan Kim, Edward B. Garon, Ji Youn Han, Ellie Im
Publikováno v:
LANCET
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Lancet, 387(10027), 1540-1550. Elsevier Limited
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Lancet, 387(10027), 1540-1550. Elsevier Limited
Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for progressive disease. We assessed the efficacy of pembrolizumab for patients with previously treated, PD-L1-p
Autor:
Zhen Wang, Wei Zhou, Marisa Dolled-Filhart, Lars Bastholt, Kenneth Emancipator, P. Switten Nielsen, Y. Feng, Torben Steiniche, A. Vestergaard Danielsen, Michael Busch-Sørensen, Henrik Schmidt, Inge Marie Svane, Russell Weiner
Publikováno v:
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 7, pp. e319–e321 . https://doi.org/10.1111/jdv.14106
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology. Supplement, vol. 31, no. 7, pp. e319-e321 . https://doi.org/10.1111/jdv.14106
Steiniche, T, Vestergaard Danielsen, A, Wang, Z, Feng, Y, Switten Nielsen, P, Bastholt, L, Schmidt, H, Svane, I M, Dolled-Filhart, M, Emancipator, K, Weiner, R, Busch-Sørensen, M & Zhou, W 2017, ' PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy ', Journal of the European Academy of Dermatology and Venereology. Supplement, vol. 31, no. 7, pp. e319-e321 . https://doi.org/10.1111/jdv.14106
The association between programmed death ligand 1 (PD-L1) expression and survival among melanoma patients treated with chemotherapy is unclear.1-5 We retrospectively characterized PD-L1 levels in patients with melanoma treated at Aarhus University Ho
Publikováno v:
Personalized medicine. 2(4)
Tissue microarrays provide a high-throughput method for assessing a large number of samples by incorporating small cores of tissue into an array that can fit onto one microscope slide. Analyses of tissue microarrays were previously limited by semiqua